The industry’s most complete portfolio of PCI products. Learn more about coronary stents, guidewires, atherectomy and more.
The 60 MHz wideband transducer in the OPTICROSS HD IVUS Catheter increases lateral and axial resolution for high image quality to visualize all vessel layers.
Brand:BOSTON SCIENTIFIC Type:Catheters Model:IMPULSE Diagnostic Catheter Flextrusion Technology Soft distal segment is designed to reduce potential for vessel trauma, allowing safe engagement and coaxial alignment in the vessel Smooth transition is designed to allow for better conformity to the anatomy an...
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products, ...
Chronic Total Occlusion (CTO) System Featuring the CROSSBOSS™ Catheter & STINGRAY™ LP System CTOs remain a difficult challenge for interventional cardiologists caring for patients with cardiovascular disease. Boston Scientific brings you the one proven system for bridging coronary CTOs via the true...
Learn about the urology procedures that Boston Scientific offers as well as urology treatment information, technology and other resources for Urologists.
Manufactured byBoston Scientific Editor Rating info User Rating info Add your Rating Categorised under:Cardio-thoracic>Coronary intervention>Guide catheters Interventional Radiology>Vascular>Guide catheters Search by Advanced search Suggest a Device
Boston Scientific Corp. 内分泌与代谢疾病 抗毒素 小分子化药 诊断用放射药物 疾病领域得分 The objective of this feasibility study is to evaluate the safety and effectiveness of the FARAFLEX™ mapping and pulsed field ablation (PFA) catheter, a novel catheter in treating persistent atrial ...
Acquisition to expand cardiovascular portfolio with complementary and differentiated calcium modification platform,furthering company's strategy to address coronary and peripheral disease MARLBOROUGH, Mass.,Jan. 8, 2025/PRNewswire/ --Boston Scientific Corporation(NYSE: BSX) today announced it has entered in...
CTOs remain a difficult challenge for interventional cardiologists caring for patients with cardiovascular disease. Boston Scientific brings you the one proven system for bridging coronary CTOs via the true lumen or subintimal pathways. Key Resources ...